US Patent

US9050309 — DPA-enriched compositions of omega-3 polyunsaturated fatty acids in free acid form

Composition of Matter · Assigned to Chrysalis Pharma AG · Expires 2033-01-04 · 7y remaining

Vulnerability score 4/100 Ironclad — strong claim type, well-established, deep family

What this patent protects

This patent protects DPA-enriched pharmaceutical compositions of polyunsaturated fatty acids in free acid form derived from fish oil.

USPTO Abstract

DPA-enriched pharmaceutical compositions of polyunsaturated fatty acids in free acid form, therapeutic methods for their use, and processes for refining the compositions from fish oil are presented.

Drugs covered by this patent

Patent Metadata

Patent number
US9050309
Jurisdiction
US
Classification
Composition of Matter
Expires
2033-01-04
Drug substance claim
Yes
Drug product claim
No
Assignee
Chrysalis Pharma AG
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.